Pharmacological Management of Apathy in Dementia.
Azhar L, Kusumo RW, Marotta G, Lanctôt KL, Herrmann N.
CNS Drugs. 2022 Feb;36(2):143-165. doi: 10.1007/s40263-021-00883-0. Epub 2022 Jan 10.
Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological Basis.
Béreau M, Van Waes V, Servant M, Magnin E, Tatu L, Anheim M.
Cells. 2023 Jun 10;12(12):1599. doi: 10.3390/cells12121599.
Apathy in Alzheimer's disease: A neurocircuitry based perspective.
Mehak SF, Shivakumar AB, Saraf V, Johansson M, Gangadharan G.
Ageing Res Rev. 2023 Jun;87:101891. doi: 10.1016/j.arr.2023.101891. Epub 2023 Mar 5.
Apathy in Parkinson's Disease.
Pagonabarraga J, Kulisevsky J.
Int Rev Neurobiol. 2017;133:657-678. doi: 10.1016/bs.irn.2017.05.025. Epub 2017 Jul 10.
The struggle of apathy in dementia.
Dening T, Baber W, Chang M, Yates J.
Aging Ment Health. 2022 Oct;26(10):1909-1911. doi: 10.1080/13607863.2021.2008309. Epub 2021 Dec 1.
Brain mechanisms underlying apathy.
Le Heron C, Holroyd CB, Salamone J, Husain M.
J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):302-312. doi: 10.1136/jnnp-2018-318265. Epub 2018 Oct 26.
Persistence of effort in apathy.
Dalléry R, Saleh Y, Manohar S, Husain M.
Rev Neurol (Paris). 2023 Dec;179(10):1047-1060. doi: 10.1016/j.neurol.2023.03.017. Epub 2023 Jul 12.
Apathy and neurocognitive correlates: review from the perspective of 'precision psychiatry'.
Gracia-García P, Modrego P, Lobo A.
Curr Opin Psychiatry. 2021 Mar 1;34(2):193-198. doi: 10.1097/YCO.0000000000000677.
Network neuroscience of apathy in cerebrovascular disease.
Tay J, Lisiecka-Ford DM, Hollocks MJ, Tuladhar AM, Barrick TR, Forster A, O'Sullivan MJ, Husain M, de Leeuw FE, Morris RG, Markus HS.
Prog Neurobiol. 2020 May;188:101785. doi: 10.1016/j.pneurobio.2020.101785. Epub 2020 Mar 6.
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.
Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D; ADMET 2 Research Group.
JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356.
